nancy lynn MD snyderman

CIK 1675198 · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.60M

Companies

4

Total Filings

37

Lifetime Open-Market Net

$94.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALKS Director 36,178 $44.28 $1.60M $10.0K 19 2026-05-22
LYRA Director 1,025 $0.70 $718 $10.0K 7 2025-05-16
Axonics, Inc. (AXNX) Delisted Director 0 $70.98 $0 $74.2K 9 2024-11-15
Future Health ESG Corp. (FHLTU) Delisted Director 22,512 $11.15 $251.0K $0 2 2021-10-26

Recent Filings · Page 3 of 4

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-10-26 Future Health ESG Corp. (FHLTU) Delisted Disp (D) −3,377 $0 EDGAR
2021-09-16 Future Health ESG Corp. (FHLTU) Delisted Buy (P) $0 EDGAR
2021-06-16 ALKS Grant (A) $0 EDGAR
2021-05-28 LYRA Grant (A) $0 EDGAR
2021-05-21 ALKS Mixed +4,700 -$30.8K EDGAR
2020-12-17 LYRA Buy (P) +1,025 $10.0K EDGAR
2020-12-04 ALKS Grant (A) $0 EDGAR
2020-10-29 LYRA Grant (A) $0 EDGAR
2020-08-26 Axonics, Inc. (AXNX) Delisted Grant (A) +3,500 $0 EDGAR
2020-05-22 ALKS Grant (A) $0 EDGAR
Showing 2130 of 37
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.